Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Prestige Consumer Healthcare Inc. (PBH:NYSE), powered by AI.
Prestige Consumer Healthcare Inc. is currently trading at $47.82. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Prestige Consumer Healthcare Inc. on Alpha Lenz.
Prestige Consumer Healthcare Inc.'s P/E ratio is 11.1.
“Prestige Consumer Healthcare Inc. trades at a P/E of 11.1 (undervalued) with solid ROE of 12.3%. Operating margin of 30.7% indicates strong profitability.”
Ask for details →Prestige Consumer Healthcare Inc. is a corporation involved in the production and distribution of over-the-counter healthcare and household cleaning products. This company primarily focuses on providing solutions for everyday health and wellness needs. It operates within the consumer staples sector, influencing industries such as healthcare, wellness, and personal care goods. Prestige Consumer Healthcare Inc. offers a range of well-known products that cater to personal health care, featuring brands that span various categories, including analgesics, cough and cold remedies, gastrointestinal aids, and oral care products. The company sells its products through multiple channels including drug stores, groceries, and e-commerce platforms, reaching a broad consumer base. Prestige Consumer Healthcare Inc.'s role in the market centers on addressing consumer demands for accessible and reliable healthcare products, reinforcing its significance as a key player in enhancing and maintaining health across diverse demographics.
“Prestige Consumer Healthcare Inc. trades at a P/E of 11.1 (undervalued) with solid ROE of 12.3%. Operating margin of 30.7% indicates strong profitability.”
Ask for details →Prestige Consumer Healthcare Inc. (ticker: PBH) is a company listed on NYSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 600 employees. Market cap is $2.4B.
The current price is $47.82 with a P/E ratio of 11.07x and P/B of 1.3x.
ROE is 12.30% and operating margin is 30.70%. Annual revenue is $1.1B.